Gilead Sciences / Заголовки новостей 
Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride
Gilead was quick to downplay a leaked WHO document showing its coronavirus treatment failed in a Chinese trial. But the numbers don't add up. The post Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride appeared first on CCN.com дальше »
2020-4-24 23:29
|
Dow Swings Wildly After Trial ‘Flop’ Ignites Coronavirus Drug Fears
The Dow Jones swung wildly after coronavirus drug remdesivir failed its first trial and ING reported a harrowing unemployment stat. The post Dow Swings Wildly After Trial ‘Flop’ Ignites Coronavirus Drug Fears appeared first on CCN.com дальше »
2020-4-24 22:20
|
|
Coronavirus Drug Could Cost 750% More Than a Flu Shot
A potential coronavirus treatment developed by Gilead Sciences could cost up to 750% more than a flu vaccine. This could constrain containment. The post Coronavirus Drug Could Cost 750% More Than a Flu Shot appeared first on CCN.com дальше »
2020-3-6 04:41
|
|